Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands. Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey. The Market Herald’s Azuka Onwuka reports ….

Read the Full Story Here


Weekly Update – Top Cannabis News Stories

1 | Top Story: Fire & Flower’s (TSX:FAF) U.S. affiliate closes US$5M convertible debenture financing

2 | Nextleaf (CSE:OILS) to launch its first THC-free CBD product

3 | Xebra Brands’ (CSE:XBRA) Vicious Citrus cannabis infused lemonade now available in Ontario

4 | HYTN (CSE: HYTN) awarded medical cannabis sales license for Kelowna facility

5 | Isracann Biosciences (CSE:IPOT) adds Mark Rypien to its advisory board

Top Cannabis Stocks August 18 to August 25, 2022

1. T.WEED | 13,479 views | Canopy Growth Corp Stock.
2. T.HEXO |10,961 views | HEXO Corp.
3. TLRY | 7,397 views | Tilray Brands Inc.
4. C.TNY | 3,120 views | Tinley Beverage Co. Inc.
5. V.LFST | 3,079 views | Lifeist Wellness Inc.
6. T.LABS | 2,078 views | Medipharm Labs Co.

New to investing in Cannabis? Check out these tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit the Cannabis Bullboards page.

More From The Market Online
Market graph

@ the Bell: Markets hover near all-time highs

A surge in commodity prices helped lift markets trading in Canada’s busiest centre on Friday to nearly reach a new all-time high.

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.